Business
Ultragenyx hisseleri, setrusumab’ın Faz III denemesinde başarısız olmasıyla %43 düştü
SOURCE:Investing Türkiye|BY:Investing.com
Failed to fetch content: Request failed with error code 403
Failed to fetch content: Request failed with error code 403